Cargando…

Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: In case of persistent atrial fibrillation (AF), atrial substrate assumes a dominant role in sustaining the arrhythmia. Recent studies prove that low voltage areas (LVA, Voltage Amplitude < 0,5 mV) represent an additional target...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregusova, N, Grossi, B, Pagani, S, Taormina, A, Cariotti, C, Poggio, L, Galimberti, P, Battaglia, V, Del Monaco, G, Latini, A C, Valcher, S, Stankowski, K, Mincione, G, Condorelli, G, Frontera, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207246/
http://dx.doi.org/10.1093/europace/euad122.017
_version_ 1785046409760735232
author Gregusova, N
Grossi, B
Pagani, S
Taormina, A
Cariotti, C
Poggio, L
Galimberti, P
Battaglia, V
Del Monaco, G
Latini, A C
Valcher, S
Stankowski, K
Mincione, G
Condorelli, G
Frontera, A
author_facet Gregusova, N
Grossi, B
Pagani, S
Taormina, A
Cariotti, C
Poggio, L
Galimberti, P
Battaglia, V
Del Monaco, G
Latini, A C
Valcher, S
Stankowski, K
Mincione, G
Condorelli, G
Frontera, A
author_sort Gregusova, N
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: In case of persistent atrial fibrillation (AF), atrial substrate assumes a dominant role in sustaining the arrhythmia. Recent studies prove that low voltage areas (LVA, Voltage Amplitude < 0,5 mV) represent an additional target for ablation of AF patients. PURPOSE: The purpose of this study is to analyse whether structural atrial conduction abnormalities (i.e., pivot sites and slow conduction corridors) may occur outside low voltage areas. METHODS: The study is based on the retrospective analysis of 31 consecutive maps of patients undergoing AF ablation (16 paroxysmal and 15 persistent cases). The clinical procedures have been performed with the support of a mapping system. Sinus rhythm activation maps and bipolar maps used for this analysis have been created with a multipolar mapping catheter. Map points were only acquired when the electrode was in contact with the endocardial tissue to avoid misleading voltage amplitude information. Slow conduction corridors and pivot sites have been analysed. At these sites, EGMs characterization included voltage amplitude (mV), signal duration (ms) and fractionation. RESULTS: The average value of EGMs amplitude reported at pivot sites and slow conduction zones, respectively, amounted to 2,08 ± 0,63 mV and 2,1 ± 0,66 mV in paroxysmal cases. In persistent cases, there were slight decreased values to 1,95 ± 0,93 mV and 1,89 ± 0,89 mV. Characterization at pivot sites documented a mean duration value of 45,4 ± 4,64 ms and 49,93 ± 5,51 ms in paroxysmal and persistent patients, respectively, while in slow conduction zones 41,53 ± 7,94 ms and 49,04 ± 6,41 ms have been reported. As for fractionation, more than five deflections per signal have been identified in all abnormal conduction areas. CONCLUSION: Our study proves that functional electrophysiological phenomena can occur outside low voltage areas, even in persistent cases. According to this analysis, not all LVA represent the correct target for catheter ablation, encouraging the development of further methods for investigation of atrial substrate.
format Online
Article
Text
id pubmed-10207246
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102072462023-05-25 Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation Gregusova, N Grossi, B Pagani, S Taormina, A Cariotti, C Poggio, L Galimberti, P Battaglia, V Del Monaco, G Latini, A C Valcher, S Stankowski, K Mincione, G Condorelli, G Frontera, A Europace 10.1.99 - Pathophysiology and Mechanisms, Other FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: In case of persistent atrial fibrillation (AF), atrial substrate assumes a dominant role in sustaining the arrhythmia. Recent studies prove that low voltage areas (LVA, Voltage Amplitude < 0,5 mV) represent an additional target for ablation of AF patients. PURPOSE: The purpose of this study is to analyse whether structural atrial conduction abnormalities (i.e., pivot sites and slow conduction corridors) may occur outside low voltage areas. METHODS: The study is based on the retrospective analysis of 31 consecutive maps of patients undergoing AF ablation (16 paroxysmal and 15 persistent cases). The clinical procedures have been performed with the support of a mapping system. Sinus rhythm activation maps and bipolar maps used for this analysis have been created with a multipolar mapping catheter. Map points were only acquired when the electrode was in contact with the endocardial tissue to avoid misleading voltage amplitude information. Slow conduction corridors and pivot sites have been analysed. At these sites, EGMs characterization included voltage amplitude (mV), signal duration (ms) and fractionation. RESULTS: The average value of EGMs amplitude reported at pivot sites and slow conduction zones, respectively, amounted to 2,08 ± 0,63 mV and 2,1 ± 0,66 mV in paroxysmal cases. In persistent cases, there were slight decreased values to 1,95 ± 0,93 mV and 1,89 ± 0,89 mV. Characterization at pivot sites documented a mean duration value of 45,4 ± 4,64 ms and 49,93 ± 5,51 ms in paroxysmal and persistent patients, respectively, while in slow conduction zones 41,53 ± 7,94 ms and 49,04 ± 6,41 ms have been reported. As for fractionation, more than five deflections per signal have been identified in all abnormal conduction areas. CONCLUSION: Our study proves that functional electrophysiological phenomena can occur outside low voltage areas, even in persistent cases. According to this analysis, not all LVA represent the correct target for catheter ablation, encouraging the development of further methods for investigation of atrial substrate. Oxford University Press 2023-05-24 /pmc/articles/PMC10207246/ http://dx.doi.org/10.1093/europace/euad122.017 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 10.1.99 - Pathophysiology and Mechanisms, Other
Gregusova, N
Grossi, B
Pagani, S
Taormina, A
Cariotti, C
Poggio, L
Galimberti, P
Battaglia, V
Del Monaco, G
Latini, A C
Valcher, S
Stankowski, K
Mincione, G
Condorelli, G
Frontera, A
Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation
title Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation
title_full Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation
title_fullStr Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation
title_full_unstemmed Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation
title_short Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation
title_sort voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation
topic 10.1.99 - Pathophysiology and Mechanisms, Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207246/
http://dx.doi.org/10.1093/europace/euad122.017
work_keys_str_mv AT gregusovan voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT grossib voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT paganis voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT taorminaa voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT cariottic voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT poggiol voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT galimbertip voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT battagliav voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT delmonacog voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT latiniac voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT valchers voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT stankowskik voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT mincioneg voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT condorellig voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation
AT fronteraa voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation